Perelman School of Medicine

Researchers from the Perelman School of Medicine at the University of Pennsylvania report this month in Cancer Research a universal approach to personalized cancer therapy based on T cells.

Aging does not appear to be a factor in poor sleep, a new study by Perelman School of Medicine at the University of Pennsylvania shows. In fact, subjective sleep quality seems to improve over a lifetime, with the fewest complaints coming from people in their 80s.

Researchers at the Perelman School of Medicine at the University of Pennsylvania have put sleeplessness on the map — literally.

Blocking autophagy -- the process of "self-eating" within cells -- is turning out to be a viable way to enhance the effectiveness of a wide variety of cancer treatments.

Injecting epilepsy patients with medication via an autoinjector -- similar to the EpiPens used to treat serious allergic reactions -- works more quickly to stop seizures than delivery of a drug via IV on board ambulances, according to a national study published today in the New England Journal of Medicine.

PHILADELPHIA — The University of Pennsylvania Graduate School of Education and Penn’s Perelman School of Medicine have launched Med Ed, a program to enhance the teaching abilities of those who teach America’s doctors. 

Gene therapy for congenital blindness has taken another step forward, as researchers further improved vision in three adult patients previously treated in one eye. After receiving the same treatment in their other eye, the patients became better able to see in dim light, and two were able to navigate obstacles in low-light situations. No adverse effects occurred.

The molecular pathway that carries time-of-day signals from the body's internal clock to ultimately guide daily behavior is like a black box, says Amita Sehgal, PhD, the John Herr Musser Professor of Neuroscience and Co-Director, Comprehensive Neuroscience Center, at the

PHILADELPHIA –- As part of its Year of Games, the University of Pennsylvania is among the 600-plus colleges and universities across the United States and Canada competing during the next eight weeks in RecycleMania 2012.

PHILADELPHIA -- Members of a University of Pennsylvania research team have shown that they can prevent, or even reverse, a blinding retinal disease, X-linked Retinitis Pigmentosa, or XLRP, in dogs.